About XSOLIS
XSOLIS is a company based in Nashville (United States) founded in 2013. XSOLIS has raised $75 million across 2 funding rounds from investors including Brighton Park Capital. The company has 166 employees as of December 31, 2022. XSOLIS has completed 1 acquisition, including MEDarchon. XSOLIS offers products and services including Dragonfly Platform, Physician Advisor Services, and Denial Services. XSOLIS operates in a competitive market with competitors including Infinx, AKASA, Plusgrade, R1 RCM and RateGain, among others.
- Headquarter Nashville, United States
- Employees 166 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$75 M (USD)
in 2 rounds
-
Latest Funding Round
$75 M (USD), Series C
Jun 28, 2021
- Investors
-
Employee Count
166
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of XSOLIS
XSOLIS offers a comprehensive portfolio of products and services, including Dragonfly Platform, Physician Advisor Services, and Denial Services.
Provides real-time analytics for patient care and utilization review.
Supplements staff with AI-driven clinical advice and coverage.
Manages appeals and documentation for revenue optimization.
People of XSOLIS
Unlock access to complete
Sales and Marketing
14 people
Software Development Team
13 people
Leadership Team
12 people
Data Analysis and Operations Team
10 people
Operations Team
8 people
Senior Team
7 people
Product Management Team
7 people
Business Team
5 people
Unlock access to complete
Funding Insights of XSOLIS
XSOLIS has successfully raised a total of $75M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $75.0M
-
First Round
First Round
(06 Sep 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series C - XSOLIS | Valuation | Brighton Park Capital |
|
| Sep, 2018 | Amount | Debt – Conventional - XSOLIS | Valuation |
investors |
|
Investors in XSOLIS
XSOLIS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brighton Park Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Brighton Park Capital is focused on growth equity investments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by XSOLIS
XSOLIS has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MEDarchon.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mobile-based care coordination system for hospitals and clinics along with analytics to predict patients at risk.
|
2012 |
Financial Statements - XSOLIS
Xsolis Comparisons
Competitors of XSOLIS
XSOLIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Infinx, AKASA, Plusgrade, R1 RCM and RateGain, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Revenue cycle management platform for healthcare is provided.
|
|
| domain | founded_year | HQ Location |
Revenue cycle automation platforms are provided for healthcare reimbursement.
|
|
| domain | founded_year | HQ Location |
SaaS revenue management solutions are offered to airlines for optimization.
|
|
| domain | founded_year | HQ Location |
End-to-end revenue cycle management is provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
SaaS solutions for hospitality revenue and operations management are delivered.
|
|
| domain | founded_year | HQ Location |
AI-enabled inventory optimization and e-commerce solutions for airlines are provided.
|
Latest news on Xsolis
Frequently Asked Questions about XSOLIS
XSOLIS was founded in 2013 and raised its 1st funding round 5 years after it was founded.
XSOLIS is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Joan Butters is the current CEO of XSOLIS.
XSOLIS is a funded company, having raised a total of $75M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $4M, raised on Sep 06, 2018.
As of Dec 31, 2022, the latest employee count at XSOLIS is 166.
XSOLIS was founded in 2013 and is headquartered in Nashville, United States. An AI-based platform is offered to physicians and payers in the healthcare sector for managing claim denials. Operations focus on analyzing potential denials during claims processing to support efficient resolution. Services include tools for identifying and addressing denial risks across payer interactions.
XSOLIS offers Dragonfly Platform, Physician Advisor Services, and Denial Services.
XSOLIS has made 1 acquisition, including MEDarchon.
XSOLIS has 1 investor. Key investors include Brighton Park Capital.